Literature DB >> 30784602

Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis.

Tadeusz Majewski1, Hui Yao2, Jolanta Bondaruk1, Woonbok Chung3, Sangkyou Lee1, June Goo Lee1, Shizhen Zhang1, David Cogdell1, Guoliang Yang1, Woonyoung Choi4, Colin Dinney5, H Barton Grossman5, Christopher Logothetis6, Steven E Scherer7, Charles C Guo1, Li Zhang8, Peng Wei9, John N Weinstein2, Jean-Pierre Issa3, Keith Baggerly10, David J McConkey11, Bogdan Czerniak12.   

Abstract

We used whole-organ mapping to study the locoregional molecular changes in a human bladder containing multifocal cancer. Widespread DNA methylation changes were identified in the entire mucosa, representing the initial field effect. The field effect was associated with subclonal low-allele frequency mutations and a small number of DNA copy alterations. A founder mutation in the RNA splicing gene, ACIN1, was identified in normal mucosa and expanded clonally with an additional 21 mutations in progression to carcinoma. The patterns of mutations and copy number changes in carcinoma in situ and foci of carcinoma were almost identical, confirming their clonal origins. The pathways affected by the DNA copy alterations and mutations, including the Kras pathway, were preceded by the field changes in DNA methylation, suggesting that they reinforced mechanisms that had already been initiated by methylation. The results demonstrate that DNA methylation can serve as the initiator of bladder carcinogenesis.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA copy alterations; DNA methylation; Whole-organ map; bladder cancer; clonal expansion; clonal origins; field effect; founder mutation; gene signature; urothelial carcinoma

Mesh:

Substances:

Year:  2019        PMID: 30784602     DOI: 10.1016/j.celrep.2019.01.095

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  11 in total

1.  A multi-omics approach to understanding the field effect in bladder cancer.

Authors:  Xue Li; Ali Hashemi Gheinani; Rosalyn M Adam
Journal:  Transl Androl Urol       Date:  2019-12

2.  The origin of bladder cancer from mucosal field effects.

Authors:  Jolanta Bondaruk; Roman Jaksik; Ziqiao Wang; David Cogdell; Sangkyou Lee; Yujie Chen; Khanh Ngoc Dinh; Tadeusz Majewski; Li Zhang; Shaolong Cao; Feng Tian; Hui Yao; Paweł Kuś; Huiqin Chen; John N Weinstein; Neema Navai; Colin Dinney; Jianjun Gao; Dan Theodorescu; Christopher Logothetis; Charles C Guo; Wenyi Wang; David McConkey; Peng Wei; Marek Kimmel; Bogdan Czerniak
Journal:  iScience       Date:  2022-06-07

Review 3.  Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.

Authors:  Soum D Lokeshwar; Maite Lopez; Semih Sarcan; Karina Aguilar; Daley S Morera; Devin M Shaheen; Bal L Lokeshwar; Vinata B Lokeshwar
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

4.  Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder.

Authors:  Kiran Tripathi; Apul Goel; Atin Singhai; Minal Garg
Journal:  Mol Biol Rep       Date:  2021-02-23       Impact factor: 2.316

5.  DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups.

Authors:  Zijian Tian; Lingfeng Meng; Xingbo Long; Tongxiang Diao; Maolin Hu; Miao Wang; Ming Liu; Jianye Wang
Journal:  Cancer Cell Int       Date:  2020-06-17       Impact factor: 5.722

6.  Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma.

Authors:  Gottfrid Sjödahl; Pontus Eriksson; Oliver Patschan; Nour-Al-Dain Marzouka; Lovisa Jakobsson; Carina Bernardo; Kristina Lövgren; Gunilla Chebil; Ellen Zwarthoff; Fredrik Liedberg; Mattias Höglund
Journal:  Int J Cancer       Date:  2019-11-14       Impact factor: 7.396

Review 7.  Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet.

Authors:  Victor G Martinez; Ester Munera-Maravilla; Alejandra Bernardini; Carolina Rubio; Cristian Suarez-Cabrera; Cristina Segovia; Iris Lodewijk; Marta Dueñas; Mónica Martínez-Fernández; Jesus Maria Paramio
Journal:  Front Genet       Date:  2019-11-18       Impact factor: 4.599

8.  Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.

Authors:  Pradeep S Chauhan; Kevin Chen; Ramandeep K Babbra; Wenjia Feng; Nadja Pejovic; Armaan Nallicheri; Peter K Harris; Katherine Dienstbach; Andrew Atkocius; Lenon Maguire; Faridi Qaium; Jeffrey J Szymanski; Brian C Baumann; Li Ding; Dengfeng Cao; Melissa A Reimers; Eric H Kim; Zachary L Smith; Vivek K Arora; Aadel A Chaudhuri
Journal:  PLoS Med       Date:  2021-08-31       Impact factor: 11.069

9.  Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.

Authors:  Cheng-Shuo Huang; Jar-Yi Ho; Jung-Hwa Chiang; Cheng-Ping Yu; Dah-Shyong Yu
Journal:  Cells       Date:  2020-06-07       Impact factor: 6.600

10.  Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship.

Authors:  Nour-Al-Dain Marzouka; David Lindgren; Pontus Eriksson; Gottfrid Sjödahl; Carina Bernardo; Fredrik Liedberg; Håkan Axelson; Mattias Höglund
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.